Skip to main content
OpenTrials
Completed

NCT Number: NCT05050526

Real-time Videoconference-based Exercise in Eldercare Workers

Formal caregiving of elderly dependent people is a both physically and psychologically demanding job, and both musculoskeletal and mental disorders with a negative impact in general health and quality of life are habitual among eldercare workers. Previous research has shown that physical exercise programs can reduce and/or prevent those disorders, consequently improving well-being at work.

Online exercise interventions might be a cost-effective tool, as they can reach a large number of people at a relatively low cost. Moreover, they are compatible with situations in which interpersonal physical distancing is required, such as the current COVID-19 pandemic. However, real-time videoconference-based exercise interventions have not yet been studied in working populations.

Thus, the aim of this study is to assess the effects of a real-time videoconference-based exercise intervention in eldercare workers. The primary outcome will be low back pain. Pain in neck, shoulders and wrists/hands will also be recorded, as well as additional measures of physical fitness, psychoaffective state, health and work-related variables. All outcomes will be measured at baseline and at 12-week and 48-week follow-ups.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain Behavior Mental Disorders Motor Activity Musculoskeletal Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Residencia Aspaldiko, Portugalete, Bizkaia, Spain

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Professional eldercare workers with ≥3 months of experience in the profession
  • Employment contract at least until the anticipated date of study end

Exclusion criteria

  • Pregnancy
  • Contraindication to exercise according to the American College of Sports Medicine Guidelines

Treatment and study plan

Real-time videoconference-based Exercise program

Behavioral

12-week exercise program consisting of two weekly 45 minute group-based sessions, remotely supervised by a professional via real-time videoconference. Each session will consist of a warm-up (5-10 min), general strengthening (30 min) and cool-down (5-10 min). Warm-up will include general joint mobility and exercises focused on increasing heart rate. General strengthening will include 4 series of 6 exercises (2 for lower limb, 2 for upper limb and 2 for the trunk) performed with minimal equipment, combining body-weight and elastic-band exercises. Three difficulty levels will be set for each of the exercises, and progression will be made at weeks 5 and 9. Participants will be asked to work in a given rate of perceived exertion (between 3 and 5 in Borg's CR10 scale) and not to reach failure in any of the exercises. Cool-down will include stretching and breathing/relaxing exercises.

Primary outcomes

  1. Change from baseline average pain intensity at 12 weeks

    Time frame: At baseline and at 12-week follow-up

    Average pain intensity during the last 7 days in a Numerical Rating Scale for pain ranging from 0 (complete absence of pain) to 10 (worst imaginable pain). This information will be collected for pain in the low back, neck, shoulders and wrists/hands.

  2. Change from baseline average pain intensity at 48 weeks

    Time frame: At baseline and at 48-week follow-up

    Average pain intensity during the last 7 days in a Numerical Rating Scale for pain ranging from 0 (complete absence of pain) to 10 (worst imaginable pain). This information will be collected for pain in the low back, neck, shoulders and wrists/hands.

  3. Change from baseline highest pain intensity at 12 weeks

    Time frame: At baseline and at 12-week follow-up

    Highest pain intensity during the last 7 days in a Numerical Rating Scale for pain ranging from 0 (complete absence of pain) to 10 (worst imaginable pain). This information will be collected for pain in the low back, neck, shoulders and wrists/hands.

  4. Change from baseline highest pain intensity at 48 weeks

    Time frame: At baseline and at 48-week follow-up

    Highest pain intensity during the last 7 days in a Numerical Rating Scale for pain ranging from 0 (complete absence of pain) to 10 (worst imaginable pain). This information will be collected for pain in the low back, neck, shoulders and wrists/hands.

  5. Change from baseline pain frequency at 12 weeks

    Time frame: At baseline and at 12-week follow-up

    Number of days in pain during the last 7 days (0-7). This information will be collected for pain in the low back, neck, shoulders and wrists/hands.

  6. Change from baseline pain frequency at 48 weeks

    Time frame: At baseline and at 48-week follow-up

    Number of days in pain during the last 7 days (0-7). This information will be collected for pain in the low back, neck, shoulders and wrists/hands.

  7. Change from baseline pain interference at 12 weeks

    Time frame: At baseline and at 12-week follow-up

    Number of days in which pain negatively interferes with work during the last 7 days of work (0-7). This information will be collected for pain in the low back, neck, shoulders and wrists/hands.

  8. Change from baseline pain interference at 48 weeks

    Time frame: At baseline and at 48-week follow-up

    Number of days in which pain negatively interferes with work during the last 7 days of work (0-7). This information will be collected for pain in the low back, neck, shoulders and wrists/hands.

Secondary outcomes

  1. Analgesic medication consumption frequency

    Time frame: At baseline and at 12-week and 48-week follow-ups

    Number of days in which analgesic medication is taken during the last 7 days (0-7).

  2. 5-repetition sit-to-stand test

    Time frame: At baseline and at 12-week and 48-week follow-ups

    It measures lower limb strength based on the time taken by the participant to get up from and sit down on a chair five times as quickly as possible.

  3. Kneeling push-up test

    Time frame: At baseline and at 12-week and 48-week follow-ups

    It measures upper limb strength based on the maximum number of "knee push-ups" the participant can perform until failure.

  4. Shirado-Ito trunk flexor endurance test

    Time frame: At baseline and at 12-week and 48-week follow-ups

    It measures trunk flexor endurance based on the maximum time the participant is able to maintain a defined body position, which mainly activates trunk flexor muscles.

  5. Subjective Happiness scale

    Time frame: At baseline and at 12-week and 48-week follow-ups

    It is comprised of 4 items, each of them answered with a score between 1 and 7. A single composite score is obtained by averaging the responses to the 4 items, and a higher score corresponds to a greater happiness.

  6. Goldberg Anxiety and Depression scale

    Time frame: At baseline and at 12-week and 48-week follow-ups

    The scale includes 9 items for anxiety symptoms and 9 items for depression symptoms. Each item is answered with a "Yes" or a "No". A higher number of positive answers corresponds to a higher risk of suffering a clinically relevant anxiety or depression disorder, respectively.

  7. Maslach Burnout Inventory

    Time frame: At baseline and at 12-week and 48-week follow-ups

    The Inventory is comprised of 22 items corresponding to three domains: personal accomplishment, emotional exhaustion and depersonalization. Each item is answered in a 0-6 Likert scale depending on the frequency with which the participant experiences the feelings described. One total score per domain is obtained.

  8. Single-Item Sleep Quality Scale

    Time frame: At baseline and at 12-week and 48-week follow-ups

    It evaluates overall sleep quality in the last 7 days with a numerical scale that ranges between 0 (terrible) and 10 (excellent).

  9. Hypnotic/anxiolytic medication consumption frequency

    Time frame: At baseline and at 12-week and 48-week follow-ups

    Number of days in which hypnotic/anxiolytic medication is taken during the last 7 days (0-7).

  10. EuroQol-5D 0-100 health state scale

    Time frame: At baseline and at 12-week and 48-week follow-ups

    It measures self-perceived current health state in a scale ranging from 0 (worst imaginable health state) to 100 (best imaginable health state).

  11. Work Ability

    Time frame: At baseline and at 12-week and 48-week follow-ups

    Work ability will be assessed by the following item extracted from the Workability Index: "assuming that your work ability at its best has a value of 10 points, how many points would you rate your current work ability?". Participants are asked to give a score ranging from 0 (completely unable to work) to 10 (lifetime best work ability).

  12. Work Performance

    Time frame: At baseline and at 12-week and 48-week follow-ups

    Work performance will be assessed by the following item extracted from the World Health Organization Health and Work Performance Questionnaire: "On a scale from 0 to 10 where 0 is the worst job performance anyone could have at your job and 10 is the performance of a top worker, how would you rate your overall work performance on the days you worked during the last 12 weeks?" Participants are asked to give a score between 0 and 10.

  13. Borg's CR-10 scale for perceived physical exertion at work

    Time frame: At baseline and at 12-week and 48-week follow-ups

    It measures perceived physical exertion while doing physical work in a scale ranging from 0 (nothing at all) to 10 (extremely strong).

  14. Absenteeism

    Time frame: At baseline and at 12-week and 48-week follow-ups

    Days of absence from work during the last year will be collected from the official registry of the company and by self-reported questionnaire. Presence of absenteeism (yes/no), days of absence (n) and reason will be collected.

Sponsors and collaborators

Lead sponsor

Ander Espin

Other

Collaborators

  • Caser Residencial Betharram
  • Fundación Aspaldiko
  • Grupo Colisée
  • Grupo Servicios Sociales Integrados
  • Igurco Residencias Sociosanitarias

Registry information

Official study title

Effects of a Real-time Videoconference-based Exercise Program in Eldercare Workers: a Randomized Controlled Trial

Acronym: ReViEEW

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Sep 20, 2021
Registry last updated
May 24, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.